Suchergebnisse - "Spiekermann, Karsten"

PubPharm (22)

1

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

enthalten in: Blood | 2018

von Herrmann, M. | Krupka, C. | Deiser, K. | +11

CommentIn: Blood. 2018 Dec 6;132(23):2425-2427. - PMID 30523124

2

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

enthalten in: Blood | 2016

von Metzeler, K. | Herold, T. | Rothenberg-Thurley, M. | +23

3

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

enthalten in: Blood | 2016

von Metzeler, K. | Herold, T. | Rothenberg-Thurley, M. | +22

4

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy : report of a large prospective multicenter trial

enthalten in: Blood | 2014

von Hoelzer, D. | Walewski, J. | Döhner, H. | +22

5

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis

enthalten in: Blood | 2014

von Herold, T. | Metzeler, K. | Vosberg, S. | +25

6

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis

enthalten in: Blood | 2014

von Herold, T. | Metzeler, K. | Vosberg, S. | +25

7

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330

enthalten in: Blood | 2014

von Krupka, C. | Kufer, P. | Kischel, R. | +12

8

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cellengaging antibody AMG 330

enthalten in: Blood | 2014

von Krupka, C. | Kufer, P. | Kischel, R. | +12

9

Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia

enthalten in: Blood | 2013

von Opatz, S. | Polzer, H. | Herold, T. | +20

10

Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia

enthalten in: Blood | 2013

von Opatz, S. | Polzer, H. | Herold, T. | +20